Cancer patients get chance to continue promising treatment
NCT ID NCT06987058
Summary
This study allows cancer patients who are already benefiting from RVU120 treatment in a previous trial to continue receiving it. It aims to monitor safety and track how long patients can stay on the treatment. Only 10 participants who show continued benefit and cannot access standard commercial treatments will be included.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinica Universidad de Navarra
Pamplona, 31008, Spain
Contact
-
Uniwersyteckie Centrum Kliniczne
Gdansk, 80-214, Poland
Contact
Conditions
Explore the condition pages connected to this study.